TITLE

Weekly Deal Wrap

PUB. DATE
November 2010
SOURCE
Mergers & Acquisitions Report;11/15/2010, Vol. 23 Issue 46, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs concerning mergers and acquisitions. GlaxoSmithKline PLC is looking to purchase a 19.9% stake in Amicus Therapeutics Inc. The multi-source injectables business of Baxter Healthcare Corp. will be acquired by Hikma Pharmaceuticals PLC. Canesta Inc. will be acquired by Microsoft Corp.
ACCESSION #
55236768

 

Related Articles

  • Hikma agreed to acquire Egypt's EIMC United Pharmaceuticals.  // African Business News;9/8/2015, p1 

    No abstract available.

  • Preflucel vaccine batches recalled, increase in ADR reports.  // Reactions Weekly;10/29/2011, Issue 1375, p3 

    The article reports that Baxter Healthcare is recalling all the remaining stock of Preflucel influenza virus vaccine in Great Britain due to an expected increased adverse drug reactions (ADR).

  • NEWS IN BRIEF.  // MEED: Middle East Economic Digest;9/23/2006, Vol. 50 Issue 38, p34 

    The article presents updates on the Middle East economy. London, England-based Hikma Pharmaceuticals completed in mid-September 2006 the acquisition of Riyadh, Saudi Arabia-based Jazeera Pharmaceutical Industries, the first pharmaceutical company in the Gulf Cooperating Council to receive U.S....

  • More signals M&A is on the upswing. PETRYK, ANDREW K. // Smart Business Cleveland;Jul2014, Vol. 25 Issue 11, p24 

    The article discusses the projected upswing in activities for mergers and acquisitions (M&A) with the middle market's first quarter of 2014 (1Q14) accounting for 85% of sponsor deal flow while 35% is accounted for the lower middle market based on market research firm PitchBook. A table showing...

  • Cranbury biotech buys N.C. biopharma firm. Strauss, Eric // njbiz;9/7/2015, Vol. 28 Issue 36, p2 

    The article reports that Amicus Therapeutics, a biotech firm based in Cranbury, New Jersey, is acquiring Scioderm Inc., a biopharmaceutical firm focused on diseases with high unmet need, for 229 million U.S. dollars.

  • Amicus Lands $230M Deal for Fabry Chaperone Amigal.  // Bioworld Week;11/8/2010, Vol. 18 Issue 45, p2 

    The article reports on the plan of Amicus Therapeutics Inc. to get 60 million U.S. dollars for its partnership with GlaxoSmithKline PLC for the fabry disease drug Amigal.

  • CORPORATE.  // MondayMorning;11/1/2010, Vol. 18 Issue 40, p2 

    The article offers news briefs related to the medical care industry. Net income of the AstraZeneca PLC has fell down 27 percent after the entry of generic competitions for its cancer drugs Arimidex and Casodex. Kadmon Pharmaceuticals LLC owned by Sam Waksal has acquired the Three Rivers...

  • Baxter Opens Barbershop In L.A.  // WWD: Women's Wear Daily;6/24/2010, Vol. 199 Issue 132, p10 

    The article reports that Baxter Healthcare Pte Ltd. has opened its first barbershop in Los Angeles, California. Opening of the barbershop will mark company's 45th anniversary, which was founded in 1965 by Bater Finley. The barbershop will have company's personal care products and shaving tools...

  • FDA approves pediatric use of chemical poisoning treatment.  // Biomedical Market Newsletter;12/20/2010, p101 

    The article reports that the U.S. Food & Drug Administration (FDA) has approved the pediatric use of Protopam Chloride drug manufactured by Baxter Healthcare Pte Ltd. which is used to treat poisoning by organophosphate pesticides and chemicals. The drug is approved to be administered either by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics